Share on StockTwits

Core Laboratories (NYSE:CLB) declared a quarterly dividend on Tuesday, July 8th, AnalystRatings.NET reports. Investors of record on Friday, July 18th will be given a dividend of 0.50 per share on Monday, August 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.23%.

A number of research firms have recently commented on CLB. Analysts at Iberia Capital upgraded shares of Core Laboratories from a “sector perform” rating to an “outperform” rating in a research note on Wednesday, June 18th. They now have a $195.00 price target on the stock, up previously from $175.00. On the ratings front, analysts at ING Group upgraded shares of Core Laboratories to a “buy” rating in a research note on Friday, May 16th. Finally, analysts at Natixis cut their price target on shares of Core Laboratories from $190.00 to $170.00 in a research note on Tuesday, May 13th. Eight equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Core Laboratories currently has a consensus rating of “Hold” and an average price target of $180.67.

Core Laboratories (NYSE:CLB) traded down 0.34% during mid-day trading on Tuesday, hitting $162.75. The stock had a trading volume of 247,150 shares. Core Laboratories has a 52-week low of $145.07 and a 52-week high of $221.00. The stock’s 50-day moving average is $161.3 and its 200-day moving average is $183.0. The company has a market cap of $7.303 billion and a P/E ratio of 30.18.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $1.35 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.45 by $0.10. The company had revenue of $262.90 million for the quarter, compared to the consensus estimate of $283.02 million. During the same quarter in the prior year, the company posted $1.22 earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis. Analysts expect that Core Laboratories will post $5.90 EPS for the current fiscal year.

Core Laboratories N.V. (NYSE:CLB) is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.